On Thursday in Beijing, Liu Guozhong, the Chinese Vice-Premier, underscored the critical need for bolstering fundamental research and innovation in the pharmaceutical industry. During a visit to the School of Pharmaceutical Sciences at Peking University, he explored the advancements in medical research and the operational aspects of key laboratories, while also gathering insights from various stakeholders at a symposium.
Liu stressed that there should be a concentrated effort on collaborative research and the implementation of policies aimed at enhancing public health. He highlighted the significance of developing innovative medications and medical infrastructure to provide robust support for the Healthy China initiative. Acknowledging the progress that China's pharmaceutical sector has made in recent years, Liu called for united research endeavors involving businesses, universities, research facilities, and medical organizations.
He advocated for the strategic use of advanced technologies, such as artificial intelligence and big data, to expedite the creation of comprehensive life and health databases. Furthermore, Liu emphasized the necessity of broadening international collaboration and enhancing openness in the pharmaceutical technology sector to ensure the health and well-being of the population are effectively protected.
5 Comments
Habibi
Healthy China initiative? Sounds great on paper, but what about the underlying systemic corruption and lack of transparency?
BuggaBoom
International collaboration will open up new avenues for research and development. This is excellent news!
KittyKat
Openness in the pharmaceutical sectors will greatly improve overall quality and standards!
Muchacho
International collaboration... how can we trust an industry operating under strict government control?
ZmeeLove
Embracing AI and Big Data is the future of medicine. It's exciting to see China leading the way.